Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue

被引:17
作者
NievesCruz, B
Rivera, A
Cifuentes, J
Pataki, G
Matalon, S
Carlo, WA
Tanswell, AK
Freeman, B
机构
[1] UNIV ALABAMA, DEPT ANESTHESIOL, BIRMINGHAM, AL 35233 USA
[2] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35233 USA
[3] UNIV ALABAMA, DEPT BIOCHEM & MOLEC GENET, BIRMINGHAM, AL 35233 USA
[4] UNIV ALABAMA, DEPT PHYSIOL & BIOPHYS, BIRMINGHAM, AL 35233 USA
[5] UNIV TORONTO, DEPT PAEDIAT, TORONTO, ON M5G 1X8, CANADA
关键词
minimum surface tension; antioxidant enzymes; alveolar distribution; superoxide dismutase;
D O I
10.1152/ajplung.1996.270.4.L659
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pulmonary surfactant mixtures are rapidly taken up by alveolar type II cells and thus may serve as vectors for the pulmonary delivery of antioxidant enzymes to the alveolar epithelium. We prepared emulsions of Survanta with superoxide dismutase (CuZn-SOD) and catalase and quantified their cellular uptake both in vitro and in vivo. Incubations of fetal lung epithelial cells with an emulsion of Survanta plus SOD and catalase mixtures resulted in significant augmentation of SOD and catalase activities (12.8 +/- 4.6 U SOD/mu g DNA; 7.49 +/- 2.21 U catalase/mu g DNA). These numbers were significantly greater than those obtained in controls (1.8 U SOD/mu g DNA; 0.55 +/- 0.52 U catalase/mu g DNA), Survanta alone (0.43 U SOD/mu g DNA; 0.16 U catalase/mu g DNA), and SOD and catalase alone (3.47 +/- 5.2 U SOD/mu g DNA; 4.24 +/- 3.0 U catalase/mu g DNA). Intratracheal instillation of the Survanta plus SOD and catalase mixture resulted in significant augmentation of enzymes by the rat lung homogenates. Confocal microscopic analysis revealed the presence of antioxidant enzymes in the cytoplasm of epithelial cells. We concluded that Survanta supplementation, in addition to replenishing surfactant stores, can also enhance the delivery of antioxidant enzymes to alveolar epithelium both in vitro and in vivo.
引用
收藏
页码:L659 / L667
页数:9
相关论文
共 43 条
[31]   BRONCHOPULMONARY DYSPLASIA - THEN AND NOW [J].
NORTHWAY, WH .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1990, 65 (10) :1076-1081
[32]   PULMONARY DISEASE FOLLOWING RESPIRATOR THERAPY OF HYALINE-MEMBRANE DISEASE - BRONCHOPULMONARY DYSPLASIA [J].
NORTHWAY, WH ;
ROSAN, RC ;
PORTER, DY .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) :357-&
[33]  
NOTTER RH, 1984, PULMONARY SURFACTANT, P17
[34]   ADMINISTRATION OF BOVINE SUPEROXIDE-DISMUTASE FAILS TO PREVENT CHRONIC PULMONARY SEQUELAE OF NEONATAL OXYGEN EXPOSURE IN THE RAT [J].
SHAFFER, SG ;
ONEILL, DH ;
THIBEAULT, DW .
JOURNAL OF PEDIATRICS, 1987, 110 (06) :942-946
[35]  
SOLA A, 1992, LANCET, V340, P1363
[36]   PULMONARY ANTIOXIDANT ENZYME MATURATION IN THE FETAL AND NEONATAL RAT .1. DEVELOPMENTAL PROFILES [J].
TANSWELL, AK ;
FREEMAN, BA .
PEDIATRIC RESEARCH, 1984, 18 (07) :584-587
[37]   LIPOSOME-ENTRAPPED ANTIOXIDANT ENZYMES PREVENT LETHAL O-2 TOXICITY IN THE NEWBORN RAT [J].
TANSWELL, AK ;
FREEMAN, BA .
JOURNAL OF APPLIED PHYSIOLOGY, 1987, 63 (01) :347-352
[38]   PROTECTION AGAINST OXYGEN-TOXICITY BY INTRAVENOUS-INJECTION OF LIPOSOME-ENTRAPPED CATALASE AND SUPEROXIDE-DISMUTASE [J].
TURRENS, JF ;
CRAPO, JD ;
FREEMAN, BA .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (01) :87-95
[39]  
WALTHER F J, 1986, Journal of Free Radicals in Biology and Medicine, V2, P289, DOI 10.1016/S0748-5514(86)80012-5
[40]  
WALTHER FJ, 1993, PEDIATR RES, V33, P332